Beyond the Scale: What GLP-1 Drugs Are Really Doing to Your Body
Ozempic and Wegovy have become household names for weight loss, but a wave of new research reveals they are reshaping…
Author: Marcus Chen
Based in Singapore, Marcus Chen specializes in the rapidly evolving fields of genomics, CRISPR technologies, and personalized diagnostics. With a background in bioinformatics and science journalism, he explores how genetic insights are transforming patient care and reshaping the diagnostic landscape. His investigative pieces often highlight the intersection of big data, AI, and next-generation sequencing in modern medicine.
From Simulation to Clinic: How AI Is Rewriting the Rules of Drug Discovery
A 10,000-fold acceleration in molecular simulation, a hidden cancer-protein pocket missed by leading AI tools, and the first human trials…
The Immune Reset: CAR T-Cell Therapy Offers a Potential Cure for Severe Lupus
A pioneering NHS trial successfully utilizes genetically modified T-cells to drive severe, treatment-resistant lupus into remission, signaling a paradigm shift…
The Fiber Buffer: Rethinking Diet and Metabolic Health Through the Microbiome
New research highlights how specific dietary fibers and prebiotics can stabilize glucose, combat fatty liver, and outperform extreme dietary restrictions.…
Pharma’s $106 Billion Summer: The Bolt-On Strategy to Beat the Patent Cliff
How a surge in targeted mid-sized acquisitions is reshaping oncology and metabolic pipelines as major drugmakers brace for a revenue…